대조 약물로써 항히스타민제인 Ketotifen을 투여한 군에서도 76.04 ± 15.27 ng/㎖로 측정되어 천식 유발군에 비해 유의적인 감소를 나타내었다.
Within the group administered with all the antihistamine Ketotifen as a control drug, it was measured to be 76.04 ± 15.27 ng/ml, indicating a significant decrease compared to the asthma-inducing group.